Overview Financials News + Filings Key Docs Charts Ownership Insiders |
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 361.1 | 329.3 | 310.7 | 281.7 | 250.3 | 211.7 | 186.8 | 14.1 |
Revenue growth | 9.7% | 6.0% | 10.3% | 12.5% | 18.2% | 13.3% | 1225.9% | 1624.7% |
Cost of goods sold | 267.5 | 243.7 | 215.1 | 194.4 | 169.3 | 146.4 | 133.8 | 10.3 |
Gross profit | 93.6 | 85.5 | 95.6 | 87.2 | 81.0 | 65.3 | 53.0 | 3.8 |
Gross margin | 25.9% | 26.0% | 30.8% | 31.0% | 32.4% | 30.9% | 28.4% | 27.2% |
Sales and marketing | 17.1 | 12.7 | 11.7 | 11.5 | 13.7 | 12.0 | 16.3 | 2.9 |
Research and development | 18.2 | 15.8 | 12.6 | 8.1 | 5.3 | 2.6 | | |
General and administrative | 53.5 | 48.2 | 46.8 | 48.1 | 36.0 | 55.1 | 54.1 | 44.5 |
EBITA | 4.4 | 8.1 | 23.7 | 18.8 | 25.6 | -4.8 | -17.9 | -84.8 |
EBITA margin | 1.2% | 2.5% | 7.6% | 6.7% | 10.2% | -2.3% | -9.6% | -601.8% |
Amortization of intangibles | 12.7 | 12.4 | 14.5 | 13.2 | 12.7 | 12.6 | 12.1 | 0.7 |
EBIT | -8.3 | -4.3 | 9.2 | 5.6 | 12.9 | -17.4 | -30.0 | -85.5 |
EBIT margin | -2.3% | -1.3% | 3.0% | 2.0% | 5.1% | -8.2% | -16.0% | -606.7% |
Pre-tax income | -121.6 | -9.8 | 3.0 | -1.7 | 3.2 | -31.7 | -43.1 | -59.2 |
Income taxes | 1.8 | 0.2 | 0.8 | 0.1 | 0.0 | 0.0 | -14.0 | -16.6 |
Tax rate | | | 27.1% | | 1.4% | 0.0% | 32.6% | 28.0% |
Earnings from continuing ops | -123.3 | -10.1 | 2.2 | -1.7 | 3.2 | -31.7 | -29.1 | -42.6 |
Earnings from discontinued ops | | | | | -19.0 | | | -42.5 |
Net income | -123.3 | -10.1 | 2.2 | -1.7 | -17.9 | -53.2 | -29.1 | -84.5 |
Net margin | -34.2% | -3.1% | 0.7% | -0.6% | -7.2% | -25.1% | -15.6% | -599.9% |
|
Diluted EPS | ($1.51) | ($0.13) | $0.03 | ($0.02) | $0.04 | ($0.52) | ($0.65) | ($3.27) |
Shares outstanding (diluted) | 81.4 | 80.0 | 79.5 | 79.4 | 76.7 | 61.2 | 44.5 | 13.0 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|